Year: 2018 Source: Journal of the Royal Society of Medicine. (2016). 109(10): 381-392. DOI: 10.1177/0141076816666805 SIEC No: 20180454

To quantify the risk of suicidality and violence when selective serotonin and serotonin-norepinephrine reuptake inhibitors are given to adult healthy volunteers with no signs of a mental disorder.

Systematic review and meta-analysis.

Harms related to suicidality, hostility, activation events, psychotic events and mood disturbances.

Published trials identified by searching PubMed and Embase and clinical study reports obtained from the European and UK drug regulators.

Double-blind, placebo-controlled trials in adult healthy volunteers that reported on suicidality or violence or precursor events to suicidality or violence.

A total of 5787 publications were screened and 130 trials fulfilled our inclusion criteria. The trials were generally uninformative; 97 trials did not report the randomisation method, 75 trials did not report any discontinuations and 63 trials did not report any adverse events or lack thereof. Eleven of the 130 published trials and two of 29 clinical study reports we received from the regulatory agencies presented data for our meta-analysis. Treatment of adult healthy volunteers with antidepressants doubled their risk of harms related to suicidality and violence, odds ratio 1.85 (95% confidence interval 1.11 to 3.08, pā€‰=ā€‰0.02, I2ā€‰=ā€‰18%). The number needed to treat to harm one healthy person was 16 (95% confidence interval 8 to 100; Mantel-Haenszel risk difference 0.06). There can be little doubt that we underestimated the harms of antidepressants, as we only had access to the published articles for 11 of our 13 trials.

Antidepressants double the occurrence of events in adult healthy volunteers that can lead to suicide and violence.